Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bausch + Lomb Corporation (BLCO : NYSE)

• Company Description    Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. Number of Employees: 13,500

• Price / Volume Information    Yesterday's Closing Price: $13.71 Daily Weekly Monthly 20 Day Moving Average: 713,814 shares Shares Outstanding: 353.80 (millions) Market Capitalization: $4,850.65 (millions) Beta: 0.62 52 Week High: $21.69 52 Week Low: $10.45 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 18.39% 13.44% 12 Week 9.77% -7.04% Year To Date -24.09% -28.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 520 APPLEWOOD CRESCENT - VAUGHAN,A6 L4K 4B4 CAN ph: 905-695-7700 fax: - None http://www.bausch.com

• General Corporate Information    Officers Brenton L. Saunders - Chairman of the Board and Chief Executive Officer Sam Eldessouky - Executive Vice President and Chief Financial Offic Frederick J. Munsch - Senior Vice President; Controller and Chief Accoun Brett Icahn - Director Gary Hu - Director Peer Information Bausch + Lomb Corporation (CHCR) Bausch + Lomb Corporation (ESRX) Bausch + Lomb Corporation (MYDP) Bausch + Lomb Corporation (COR) Bausch + Lomb Corporation (GBCS) Bausch + Lomb Corporation (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 071705107 SIC: 3851 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 07/30/25 Share - Related Items Shares Outstanding: 353.80 Most Recent Split Date: (:1) Beta: 0.62 Market Capitalization: $4,850.65 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.19 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.47 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 18.69% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/30/25

• Fundamental Ratios P/E Current FY Estimate: 28.89 Trailing 12 Months: 28.56 PEG Ratio: 1.55 Price Ratios Price/Book: 0.75 Price/Cash Flow: 7.32 Price / Sales: 1.00 EPS Growth vs. Year Ago Period: -200.00% vs. Previous Quarter: -128.00% Sales Growth vs. Year Ago Period: 3.46% vs. Previous Quarter: -11.17% ROE 06/30/25 - - 03/31/25 - 2.62 12/31/24 - 3.35 ROA 06/30/25 - - 03/31/25 - 1.28 12/31/24 - 1.66 Current Ratio 06/30/25 - - 03/31/25 - 1.56 12/31/24 - 1.60 Quick Ratio 06/30/25 - - 03/31/25 - 0.96 12/31/24 - 1.01 Operating Margin 06/30/25 - - 03/31/25 - 3.56 12/31/24 - 4.63 Net Margin 06/30/25 - - 03/31/25 - -7.50 12/31/24 - -6.62 Pre-Tax Margin 06/30/25 - - 03/31/25 - -6.71 12/31/24 - -4.88 Book Value 06/30/25 - - 03/31/25 - 18.20 12/31/24 - 18.57 Inventory Turnover 06/30/25 - - 03/31/25 - 1.81 12/31/24 - 1.74 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.74 12/31/24 - 0.72 Debt-to-Capital 06/30/25 - - 03/31/25 - 42.67 12/31/24 - 42.03

Powered by Zacks Investment Research ©